Pictured: Robert Motzer
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Tuesday, February 7, 2012

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.

Pictured: Memorial Sloan Kettering logo
In the News
By Julie Grisham, MS, Science Writer/Editor  |  Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan Kettering investigators.

Pictured: Charles Sawyers & Howard Scher
In the News
By Media Staff  |  Friday, February 3, 2012

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Pictured: Marc Ladanyi & Laetitia Borsu
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, February 1, 2012

Memorial Sloan Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.

Pictured: Monica Morrow
Perspective
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, January 31, 2012

Breast Surgical Service Chief Monica Morrow provides perspective on assessing the quality of surgical breast cancer treatment in an editorial in the February 1 issue of the Journal of the American Medical Association.

Pictured: Stephanie Luedke
Patient Story
By Memorial Sloan Kettering  |  Monday, January 30, 2012

While a diagnosis of cervical cancer once required a hysterectomy, a procedure called a radical trachelectomy eliminated Stephanie Luedke’s cancer and preserved her ability to bear a child.

Prediction Tool
By Memorial Sloan Kettering  |  Wednesday, January 25, 2012

Our ovarian cancer nomogram is a personalized tool that can help you and your doctor make important treatment decisions after surgery.

Finding
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, January 23, 2012

Research has shown that children who have experienced a sunburn at an early age are at almost double the risk for developing melanoma in adulthood. Now, a new study led by Memorial Sloan Kettering epidemiologist Stephen Dusza finds that most children do not regularly use sunscreen.

Pictured: Eric Pamer
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Friday, January 20, 2012

Infections are a common cause of complications in cancer patients. Now a Memorial Sloan Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.

Pictured: Michael Quinlan
Patient Story
By Memorial Sloan Kettering  |  Thursday, January 19, 2012

When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.

Pictured: Mark Bilsky, Eric Lis, Josh Yamada, and George Krol
Cancer Guide
By Memorial Sloan Kettering  |  Tuesday, January 17, 2012

The Spine Tumor Center at Memorial Sloan Kettering provides state-of-the-art diagnostic and treatment services for more than 1,500 people with primary or metastatic spine tumors each year.

Pictured: Michael Morris
In the Clinic
By Media Staff  |  Friday, January 13, 2012

Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.

Pictured: Major Trends in Modern Cancer Research Seminar
Video
By Memorial Sloan Kettering  |  Thursday, January 12, 2012

Hundreds of high school students and teachers attended our sixth annual Major Trends in Modern Cancer Research seminar to learn about cutting-edge biomedical research and to engage with leading scientists.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
Feature
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, December 28, 2011

Years of innovative research, technology development, and facility expansion at Memorial Sloan Kettering have led to several new experimental treatments for people with cancer.

Pictured: Craig Thompson
Perspective
By Craig Thompson, MD, President and CEO  |  Friday, December 23, 2011

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.

Center News

Stay Informed

Get the latest information about cancer care and research every month.